Table 2.
The relationship between the degree of skewed XCI and clinical symptoms in SCZ
| SCZ patient | Patient age (years) | Age of onset (years) | Disease duration (months) | PPANSS† | NPANSS§ | Total PANSS | Medicine (mg/day) | |
|---|---|---|---|---|---|---|---|---|
| Total patient | Coefficient | 0.312 | 0.317 | −0.053 | 0.1 | −0.103 | 0.041 | 0.019 |
| Significance | 0.001 | 0.001 | 0.605 | 0.326 | 0.311 | 0.687 | 0.88 | |
| Child patient | Coefficient | 0.132 | 0.212 | −0.219 | 0.046 | −0.281 | −0.061 | −0.052 |
| Significance | 0.421 | 0.195 | 0.180 | 0.783 | 0.083 | 0.711 | 0.771 | |
| Adult patient | Coefficient | 0.129 | 0.126 | −0.198 | 0.299 | 0.077 | 0.223 | 0.286 |
| Significance | 0.391 | 0.402 | 0.193 | 0.046 | 0.614 | 0.142 | 0.236 | |
| Elderly patient | Coefficient | 0.127 | 0.345 | −0.359 | 0.282 | 0.274 | 0.248 | 0.388 |
| Significance | 0.64 | 0.208 | 0.188 | 0.308 | 0.322 | 0.372 | 0.153 | |
The relationship between degree of skewed XCI and clinical indicators analyzed by Spearman's correlation and Spearman's correlation was significant at p < 0.0167 for age group of SCZ patients.
†Positive symptoms in the PANSS
§Negative symptoms in the PANSS